ALK-Abelló A/S (OTC:AKBLF – Get Free Report) traded up 1.4% during mid-day trading on Monday . The stock traded as high as $20.59 and last traded at $20.59. 5 shares traded hands during trading, a decline of 98% from the average session volume of 300 shares. The stock had previously closed at $20.30.
ALK-Abelló A/S Price Performance
The company’s 50-day simple moving average is $20.92 and its two-hundred day simple moving average is $22.70.
ALK-Abelló A/S Company Profile
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Read More
- Five stocks we like better than ALK-Abelló A/S
- Financial Services Stocks Investing
- Energy Transfer: Powering Data With Dividends and Diversification
- What Investors Need to Know About Upcoming IPOs
- Qualcomm Stock Is Coiling for a Breakout
- Industrial Products Stocks Investing
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
